About MedBio Trials
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
1
Vertex Pharmaceuticals Incorporated
1
Clinical Trials at MedBio Trials
During the past decade, MedBio Trials conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
2020-09-14
2021-03-22
Completed
156
Phase 2/3 Adaptive Study of VX-147 in Adults and Adolescents With APOL1- Mediated Proteinuric Kidney Disease
2022-03-30
2026-06-01
Recruiting
466
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MedBio Trials
According to Clinical.Site data, the most researched conditions in "MedBio Trials" are
"COVID-19" (1 trials) and "Proteinuric Kidney Disease" (1 trials). Many other conditions were trialed in "MedBio Trials" in a lesser frequency.
Clinical Trials Intervention Types at MedBio Trials
Most popular intervention types in "MedBio Trials" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Remdesivir (RDV)" (1 trials) and "VX-147" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MedBio Trials
The vast majority of trials in "MedBio Trials" are
2 trials for "All" genders.
Clinical Trials Status at MedBio Trials
Currently, there are NaN active trials in "MedBio Trials".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MedBio Trials,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MedBio Trials, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".